Sannala, C. K. R., MacLean, C., Larsen, F., van Os, S., Jadhav, P., Shore, N., . . . Gobburu, J. (2024). A Model‐Informed Drug Development Approach to Design a Phase 3 Trial of Teverelix Drug Product in Advanced Prostate Cancer Patients with Increased Cardiovascular Risk. Clinical Pharmacology in Drug Development, 13(8), 915. https://doi.org/10.1002/cpdd.1415
Chicago Style (17th ed.) CitationSannala, Chenna Keshava Reddy, Carol MacLean, Finn Larsen, Steve van Os, Pravin Jadhav, Neal Shore, Alicia K. Morgans, Tochukwu Okwuosa, and Joga Gobburu. "A Model‐Informed Drug Development Approach to Design a Phase 3 Trial of Teverelix Drug Product in Advanced Prostate Cancer Patients with Increased Cardiovascular Risk." Clinical Pharmacology in Drug Development 13, no. 8 (2024): 915. https://doi.org/10.1002/cpdd.1415.
MLA (9th ed.) CitationSannala, Chenna Keshava Reddy, et al. "A Model‐Informed Drug Development Approach to Design a Phase 3 Trial of Teverelix Drug Product in Advanced Prostate Cancer Patients with Increased Cardiovascular Risk." Clinical Pharmacology in Drug Development, vol. 13, no. 8, 2024, p. 915, https://doi.org/10.1002/cpdd.1415.
